Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-04-10 00:00:00 ET · period of report 2025-04-09 · accession 0001140361-25-013253 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-04-10 | 2025-04-09 | RCKT | Patel Kinnari | See Remarks | P - Purchase | $4.70 | +21.1K | 26.8K | +372% | +$99.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-09 | P | A | 21,099 | $4.70 | 26,774 | I By Spouse | — | — | (F1) On April 9, 2025, the Reporting Person's husband purchased 21,099 shares of Common Stock in a series of brokered transactions at prices ranging from $4.65 to $4.78 and a weighted average price per share of $4.70 (rounded to two decimal places), for an aggregate purchase price of approximately $99,157. The detailed breakdown of executed sales will be furnished upon request. |